Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-18-062266

COO and Secretary sold 7,500 shares at an average $20.40 ($153,000)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Schuth Alexander O. COO and Secretary 2018-12-10 Sale −2,500 $20.18 $50,450 682,589 I: show line 1 in the form
Schuth Alexander O. COO and Secretary 2018-12-11 Sale −2,500 $20.22 $50,550 680,089 I: show line 2 in the form
Schuth Alexander O. COO and Secretary 2018-12-12 Sale −2,500 $20.80 $52,000 677,589 I: show line 3 in the form
Open-market sales · 7,500 sh · avg $20.40 · $153,000
Loading xslF345X03/doc4.xml…